Show simple item record

dc.contributor.authorThang, Christopher
dc.contributor.authorMarella, Prashanti
dc.contributor.authorKumar, Aashish
dc.contributor.authorMatebele, Mbakise
dc.contributor.authorRamanan, Mahesh
dc.date.accessioned2021-08-12T04:49:06Z
dc.date.available2021-08-12T04:49:06Z
dc.date.issued2021
dc.identifier.issn1053-0770
dc.identifier.doi10.1053/j.jvca.2021.07.011
dc.identifier.urihttp://hdl.handle.net/10072/406831
dc.description.abstractOBJECTIVES: To determine whether the early use of albumin after cardiac surgery in the first 24 hours in the intensive care unit (ICU) is associated with reduced mortality. DESIGN: A single-center nonrandomized retrospective cohort study using the Medical Information Mart in Intensive Care IV database. SETTING: A single cardiothoracic ICU in the United States during a period between 2008 to 2019. PARTICIPANTS: Patients undergoing valvular and/or cardiac bypass graft surgeries. INTERVENTIONS: Albumin administered during the first 24 hours of the ICU admission. MEASUREMENTS AND MAIN RESULTS: A total of 8,136 patients were included in this study, of whom 4,444 (54.6%) received albumin at any stage during the first 24 hours of ICU admission, and 69 (1.6%) of those patients died. The patient population exposed to albumin had higher comorbidities and illness severity compared to the no-albumin group. Patients exposed to albumin during the first 24 hours of ICU admission had a statistically significant reduction in mortality (odds ratio [OR], 0.68; 95% confidence interval [CI], 0.48-0.97, p < 0.05) after adjustment for age, the Oxford Acute Severity of Illness Score, and the Charlson comorbidity index. A sensitivity analysis of patients who received albumin at any stage during ICU admission showed increased mortality (OR, 1.93; 95% CI, 1.26-3.07, p < 0.01). Patients exposed to albumin had a significant increase in adjusted ICU length of stay (LOS) (geometric mean ratio 1.09; 95% CI, 1.05-1.10, p = < 0.001) and hospital LOS (geometric mean ratio 1.08; 95% CI, 1.05-1.10, p < 0.001). CONCLUSIONS: Exposure to albumin in the first 24 hours after cardiac surgery is associated with a reduction in adjusted hospital mortality and an increase in both hospital and ICU lengths of stay.
dc.description.peerreviewedYes
dc.languageeng
dc.publisherElsevier BV
dc.relation.ispartofjournalJournal of Cardiothoracic and Vascular Anesthesia
dc.subject.fieldofresearchCardiovascular medicine and haematology
dc.subject.fieldofresearchcode3201
dc.subject.keywordsalbumin
dc.subject.keywordscardiac surgery
dc.subject.keywordscrystalloids
dc.subject.keywordsfluid resuscitation
dc.subject.keywordsintensive care units
dc.titleEarly Albumin Exposure After Cardiac Surgery
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationThang, C; Marella, P; Kumar, A; Matebele, M; Ramanan, M, Early Albumin Exposure After Cardiac Surgery, Journal of Cardiothoracic and Vascular Anesthesia, 2021
dcterms.dateAccepted2021-07-05
dc.date.updated2021-08-11T00:12:39Z
gro.description.notepublicThis publication has been entered as an advanced online version in Griffith Research Online.
gro.hasfulltextNo Full Text
gro.griffith.authorThang, Chris
gro.griffith.authorMatebele, Mbakise Pula


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record